In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Zeneca acquires Glaxo Wellcome's migraine drug

Executive Summary

Zeneca has signed a memorandum of agreement to acquire Glaxo Wellcome's 5HT1D-agonist, 311C90, a migraine treatment in Phase III trials.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Product Purchase

Related Companies

UsernamePublicRestriction

Register